{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:54:51Z","timestamp":1784829291045,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bioorg.2019.103529","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T11:15:25Z","timestamp":1576840525000},"page":"103529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Novel N,N-dimethylbarbituric-pyridinium derivatives as potent urease inhibitors: Synthesis, in vitro, and in silico studies"],"prefix":"10.1016","volume":"95","author":[{"given":"Mahmood","family":"Biglar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghieh","family":"Mirzazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saghi","family":"Sepehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaghoub","family":"Sarrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud","family":"Amanlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mohammadi-Khanaposhtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103529_b0005","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.bmcl.2017.05.019","article-title":"Synthesis and molecular docking study of some 5, 6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease","volume":"27","author":"Mentese","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103529_b0010","doi-asserted-by":"crossref","first-page":"2789S","DOI":"10.1093\/jn\/131.10.2789S","article-title":"Helicobacter pylori: ulcers and more: the beginning of an era","volume":"131","author":"Lacy","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.bioorg.2019.103529_b0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bioorg.2018.05.017","article-title":"1-[(4\u2032-Chlorophenyl) carbonyl-4-(aryl) thiosemicarbazide derivatives as potent urease inhibitors: Synthesis, in vitro and in silico studies","volume":"79","author":"Ali","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103529_b0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bioorg.2018.10.031","article-title":"Synthesis, in vitro urease inhibition and molecular docking studies of some novel quinazolin-4 (3H)-one derivatives containing triazole, thiadiazole and thiosemicarbazide functionalities","volume":"83","author":"Mente\u015fe","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103529_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103235","article-title":"Design, synthesis, in vitro evaluation, molecular docking and ADME properties studies of hybrid bis-coumarin with thiadiazole as a new inhibitor of Urease","volume":"92","author":"Alomari","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103529_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103112","article-title":"Synthesis of new arylhydrazide bearing Schiff bases\/thiazolidinone: \u03b1-amylase, urease activities and their molecular docking studies","volume":"91","author":"Rahim","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103529_b0035","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1016\/j.bmc.2016.07.052","article-title":"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation","volume":"24","author":"Shi","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103529_b0040","first-page":"7060","article-title":"Design, synthesis and anticancer evaluation of oxa\/thiadiazolylhydrazones of barbituric and thiobarbituric acid: a collective in vitro and in silico approach","volume":"3","author":"Bhatt","year":"2018","journal-title":"Chem. Select."},{"key":"10.1016\/j.bioorg.2019.103529_b0045","first-page":"1000126","article-title":"Design, synthesis and comparative study of anti-microbial activities on barbituric acid and thiobarbituric acid based chalcone derivatives bearing the pyrimidine nucleus","volume":"7","author":"Dhorajiya","year":"2016","journal-title":"Chem. Sci. J."},{"key":"10.1016\/j.bioorg.2019.103529_b0050","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.3390\/molecules20033582","article-title":"Antibacterial barbituric acid analogues inspired from natural 3-acyltetramic acids; synthesis, tautomerism and structure and physicochemical property-antibacterial activity relationships","volume":"20","author":"Jeong","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103529_b0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jfluchem.2012.06.032","article-title":"Synthesis and biological evaluation of new barbituric and thiobarbituric acid fluoro analogs of benzenesulfonamides as antidiabetic and antibacterial agents","volume":"142","author":"Faidallah","year":"2012","journal-title":"J. Fluorine. Chem."},{"key":"10.1016\/j.bioorg.2019.103529_b0060","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cclet.2015.12.035","article-title":"Development of bis-thiobarbiturates as successful urease inhibitors and their molecular modeling studies","volume":"27","author":"Rahim","year":"2016","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103529_b0065","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1016\/j.bmc.2014.05.057","article-title":"Synthesis and structure\u2013activity relationship of thiobarbituric acid derivatives as potent inhibitors of urease","volume":"22","author":"Khan","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103529_b0070","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/j.bmc.2015.05.038","article-title":"Design and synthesis of new barbituric-and thiobarbituric acid derivatives as potent urease inhibitors: Structure activity relationship and molecular modeling studies","volume":"23","author":"Rauf","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103529_b0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bioorg.2018.06.007","article-title":"Synthesis, in vitro urease inhibitory activity, and molecular docking studies of thiourea and urea derivatives","volume":"80","author":"Bano","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103529_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8517243","article-title":"Synthesis, X-ray crystal structures, biological evaluation, and molecular docking studies of a series of barbiturate derivatives","author":"Barakat","year":"2016","journal-title":"J. Chem."},{"key":"10.1016\/j.bioorg.2019.103529_b0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13065-015-0140-1","article-title":"Synthesis and dynamics studies of barbituric acid derivatives as urease inhibitors","volume":"9","author":"Barakat","year":"2015","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2019.103529_b0090","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1007\/s00894-011-1310-2","article-title":"Large-scale virtual screening for the identification of new Helicobacter pylori urease inhibitor scaffolds","volume":"18","author":"Azizian","year":"2012","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.bioorg.2019.103529_b0095","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s13738-015-0617-9","article-title":"Synthesis of novel 5-arylidene (thio) barbituric acid and evaluation of their urease inhibitory activity","volume":"12","author":"Vosooghi","year":"2015","journal-title":"J. Iran Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103529_b0100","doi-asserted-by":"crossref","first-page":"1800005","DOI":"10.1002\/ardp.201800005","article-title":"Synthesis, evaluation, and molecular docking studies of aryl urea-triazole-based derivatives as anti-urease agents","volume":"351","author":"Moghimi","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2019.103529_b0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2019.103529_b0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bioorg.2019.103529_b0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/cn200100h","article-title":"Knowledge-based, Central Nervous System (CNS) lead selection and lead optimization for CNS drug discovery","volume":"3","author":"Ghose","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103529_b0120","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819312787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819312787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:53:42Z","timestamp":1758614022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819312787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":24,"alternative-id":["S0045206819312787"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103529","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel N,N-dimethylbarbituric-pyridinium derivatives as potent urease inhibitors: Synthesis, in vitro, and in silico studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103529"}}